A phase II randomised study to evaluate the efficacy of aprepitant plus palonosetron for preventing delayed‐phase CINV associated with TC therapy in gynaecological cancer
Yayoi Sugimori; Tsuyoshi Ota; Takafumi Ujihira; Tomonori Ishiguro; Daiki Ogishima
Author Information: Department of Obstetrics and Gynecology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.